Kentucky Retirement Systems Insurance Trust Fund Has $1.28 Million Stake in Agilent Technologies, Inc. (NYSE:A)

Kentucky Retirement Systems Insurance Trust Fund lessened its position in Agilent Technologies, Inc. (NYSE:A) by 8.6% in the third quarter, Holdings Channel.com reports. The firm owned 8,638 shares of the medical research company’s stock after selling 814 shares during the quarter. Kentucky Retirement Systems Insurance Trust Fund’s holdings in Agilent Technologies were worth $1,283,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of A. Crewe Advisors LLC grew its holdings in shares of Agilent Technologies by 114.8% during the second quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock worth $25,000 after purchasing an additional 101 shares during the last quarter. Livelsberger Financial Advisory acquired a new stake in Agilent Technologies during the 3rd quarter worth approximately $28,000. Ridgewood Investments LLC bought a new stake in Agilent Technologies during the 2nd quarter worth approximately $29,000. Ashton Thomas Securities LLC bought a new position in shares of Agilent Technologies during the third quarter valued at $31,000. Finally, Fortitude Family Office LLC lifted its holdings in shares of Agilent Technologies by 68.3% during the third quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company’s stock worth $35,000 after purchasing an additional 95 shares during the period.

Insider Activity

In other news, CEO Padraig Mcdonnell sold 1,958 shares of the business’s stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total value of $283,910.00. Following the transaction, the chief executive officer now owns 24,118 shares in the company, valued at $3,497,110. The trade was a 7.51 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Dominique Grau sold 9,990 shares of the stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total value of $1,448,550.00. Following the sale, the senior vice president now directly owns 40,011 shares of the company’s stock, valued at $5,801,595. The trade was a 19.98 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 11,995 shares of company stock worth $1,739,510 over the last 90 days.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the company. UBS Group raised their target price on Agilent Technologies from $141.00 to $150.00 and gave the stock a “neutral” rating in a research report on Thursday, August 22nd. Stifel Nicolaus reaffirmed a “buy” rating and issued a $151.00 price objective on shares of Agilent Technologies in a research note on Monday, August 26th. Evercore ISI increased their target price on shares of Agilent Technologies from $135.00 to $145.00 and gave the company an “in-line” rating in a research report on Tuesday, October 1st. Citigroup boosted their price target on shares of Agilent Technologies from $150.00 to $165.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. Finally, TD Cowen increased their price objective on shares of Agilent Technologies from $153.00 to $160.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. One research analyst has rated the stock with a sell rating, five have issued a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $144.36.

Agilent Technologies Stock Down 2.4 %

Shares of NYSE:A opened at $127.07 on Friday. The firm has a market cap of $36.51 billion, a P/E ratio of 26.36, a PEG ratio of 5.91 and a beta of 1.07. Agilent Technologies, Inc. has a 52-week low of $112.06 and a 52-week high of $155.35. The business’s 50 day simple moving average is $138.73 and its two-hundred day simple moving average is $138.00. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.37 and a current ratio of 1.78.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, August 21st. The medical research company reported $1.32 EPS for the quarter, beating analysts’ consensus estimates of $1.26 by $0.06. Agilent Technologies had a net margin of 21.75% and a return on equity of 25.26%. The business had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.56 billion. During the same quarter in the previous year, the business posted $1.43 EPS. Agilent Technologies’s quarterly revenue was down 5.6% on a year-over-year basis. As a group, research analysts forecast that Agilent Technologies, Inc. will post 5.24 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, October 23rd. Shareholders of record on Tuesday, October 1st were issued a dividend of $0.236 per share. This represents a $0.94 dividend on an annualized basis and a yield of 0.74%. The ex-dividend date of this dividend was Tuesday, October 1st. Agilent Technologies’s dividend payout ratio is currently 19.50%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.